Investigate The Influence Of Supply Chain Dynamics On The Availability And Price Of Generic Alternatives To Branded Drugs, With A Focus On Diabetes And Hypertension Treatments.

Abstract

This study investigates the impact of supply chain dynamics on the availability and affordability of generic alternatives to branded pharmaceuticals, with a focus on diabetes and hypertension treatments. Given the global frequency of many chronic illnesses, access to cheap pharmaceuticals is crucial for controlling and minimising their impact on public health. The availability and affordability of generic alternatives are heavily influenced by the complex interaction of supply chain factors such as regulatory frameworks, distribution networks, pricing systems, and market rivalry. This study attempts to understand the mechanisms by which supply chain dynamics influence the accessibility and affordability of diabetes and blood pressure drugs through a comprehensive inquiry that includes both qualitative and quantitative evaluations.

Using data from a wide range of sources, including regulatory documents, market studies, and stakeholder interviews, the study aims to identify important barriers and facilitators influencing the availability and pricing of generic alternatives along the supply chain. The study's findings, which shed light on these dynamics, have the potential to improve legislative actions, corporate tactics, and healthcare practices targeted at improving access to vital pharmaceuticals for those suffering from diabetes and high blood pressure.